NewsEvents

Your Yourlocation: Home > Treatment of doxofylline combined with tiotropium bromide(136310-93-5)

Lengshuijiang Municipal People's Hospital, Wei Dongming and others studied of the combination of doxofylline and tiotropium bromide(136310-93-5) powder in patients with chronic obstructive pulmonary disease pulmonary function of the clinical observation, the study found that Doxofylline combined with tiotropium bromide(136310-93-5) powder Treatment of chronic obstructive pulmonary disease clinical effect is obvious, worthy of promotion and application. The article published on 2016 03 period "Chinese Medicine Guide".

The aim of this study was to investigate the effects of doxofylline combined with tiotropium on pulmonary function in patients with chronic obstructive pulmonary disease (COPD).

We retrospectively analyzed the clinical data of 122 patients with chronic obstructive pulmonary disease who were treated in our hospital from March 2010 to March 2014. 122 patients were divided into observation group and control group, Sixty-one patients were treated with doxofylline and tiotropium bromide(136310-93-5) powder, and 61 patients in the control group were treated with doxofylline alone. The clinical treatment of the two groups was observed.

The results showed that the total effective rate was 95.08% in the observation group and 70.49% in the control group. Compared with the control group, the lung function and the quality of life of the observation group were better than the reference group (P <0.05).


Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved